Expression of Transferrin Receptor in Normal Human Skin, Psoriatic Skin and Various Skin Tumors

1988 ◽  
Vol 15 (3) ◽  
pp. 208-211 ◽  
Author(s):  
Mitsuru Iwata ◽  
Fujio Otsuka ◽  
Shin-ichi Watanabe ◽  
Tatsutoshi Nogita ◽  
Yasumasa Ishibashi
1996 ◽  
Vol 288 (10) ◽  
pp. 625-627 ◽  
Author(s):  
M. Sakai ◽  
Yoshinori Shimizu ◽  
Ikuko Nagatsu ◽  
Hiroshi Ueda

1995 ◽  
Vol 22 (2) ◽  
pp. 88-94 ◽  
Author(s):  
Nami Yasaka ◽  
Masutaka Furue ◽  
Kunihiko Tamaki

2015 ◽  
Vol 20 (6) ◽  
pp. 067004 ◽  
Author(s):  
Marie Leroy ◽  
Thierry Lefèvre ◽  
Roxane Pouliot ◽  
Michèle Auger ◽  
Gaétan Laroche

1996 ◽  
Vol 288 (10) ◽  
pp. 625-627 ◽  
Author(s):  
Masao Sakai ◽  
Yoshinori Shimizu ◽  
Ikuko Nagatsu ◽  
Hiroshi Ueda

1984 ◽  
Vol 12 (2) ◽  
pp. 89-97
Author(s):  
Graham R. Elliott ◽  
H.E. Amos ◽  
James W. Bridges

The rate of growth of normal human skin fibroblasts was inhibited in a dose related, reversible, fashion by practolol (N-4-(2-hydroxy)-3 (1-methyl)-aminopropoxyphenylacetamine) (ID50 1.35 ± 0.14 x 10-3M), propranolol (1-(isopropylamino)-3(1-naphthyl-oxy)-2-propranolol) (ID50 0.145 ± 0.02 x 10-3M) and paracetamol (N-(4-hydroxyphenyl) acetamide) (ID50 0.85 ± 0.2 x 10-3M). Skin fibroblasts isolated from a psoriasis patient were more sensitive towards practolol (ID50 0.48 ± 0.14 x 10-3M) and propranolol (ID50 0.032 ± 0.002 x 10-3M), but less sensitive towards paracetamol (ID50 1.3 ± 0.07 x 10-3M). In vitro generated metabolites of practolol, using normal or Arochlor 1254-pretreated hamster liver preparations, and structural analogues of practolol had no effect upon the growth of either cell type.


Sign in / Sign up

Export Citation Format

Share Document